KITE

Kite Pharma Inc

A developer of engineered cell therapies for cancer, Kite Pharma makes Yescarta, a personalized treatment that reprograms a patient's own immune cells to attack certain lymphomas. Founded in Santa Monica, California in 2009, the company was acquired by Gilead Sciences in 2017. The name nods to a kite soaring upward, symbolizing ambition and rising to meet cancer.

No proxy statement recorded.